Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06590935
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-29
Brief Title:
Endocrine and Exocrine Secretory Function Alterations After Moderately Severe and Severe Acute Pancreatitis
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Prospective Cohort Study on Endocrine and Exocrine Secretory Function Alterations After Moderately Severe and Severe Acute Pancreatitis
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational study is to learn about post-acute pancreatitis diabetes mellitus PPDM-A The main questions it aims to answer are
1 Are the incident rates of glucose metabolic disorders pre-diabetes and diabetes mellitus after acute pancreatitis of different etiologies the same
2 Are alterations in endocrine and exocrine secretory function in patients with acute pancreatitis associated with all-round outcomes
All patients with acute pancreatitis have been given the standardized treatment for the condition
Investigators will compare the incident rates of glucose metabolic disorders pre-diabetes and diabetes mellitus after acute pancreatitis of different etiologies in patients with moderately severe MSAP and severe acute pancreatitis SAP to explore the association between alterations in endocrine and exocrine secretory function and all-round outcomes
1 Are the incident rates of glucose metabolic disorders pre-diabetes and diabetes mellitus after acute pancreatitis of different etiologies the same
2 Are alterations in endocrine and exocrine secretory function in patients with acute pancreatitis associated with all-round outcomes
All patients with acute pancreatitis have been given the standardized treatment for the condition
Investigators will compare the incident rates of glucose metabolic disorders pre-diabetes and diabetes mellitus after acute pancreatitis of different etiologies in patients with moderately severe MSAP and severe acute pancreatitis SAP to explore the association between alterations in endocrine and exocrine secretory function and all-round outcomes
Detailed Description:
Investigators will prospectively collect data from patients with moderately severe MSAP and severe acute pancreatitis SAP in participant centers
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None